Tyler Zeronda

Tyler Zeronda

No open positions remaining

Net worth: 52 460 $ as of 2026-07-30

40 year
Health Technology
Consumer Services

Profile

Tyler Zeronda is currently Chief Financial Officer at Yarrow Bioscience, Inc. since 2026.
Formerly, Mr. Zeronda was Chief Financial Officer at VYNE Therapeutics, Inc. from 2021 to 2022, Vice President-Finance at VYNE Pharmaceuticals Ltd. from 2019 to 2020, and Finance Director at Aerie Pharmaceuticals, Inc. from 2013 to 2019.
Education includes graduate studies at the University of Virginia and undergraduate studies at Lafayette College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.05%
2026-07-26 1,498 ( 0.05% ) 52 460 $ 2026-07-30

Tyler Zeronda active positions

CompaniesPositionStart

Former positions of Tyler Zeronda

CompaniesPositionEnd
Corporate Officer/Principal 2019-12-31
AERIE PHARMACEUTICALS, INC. Director of Finance/CFO 2019-03-31
YARROW BIOSCIENCE, INC. Director of Finance/CFO -
See the detail of Tyler Zeronda's experience

Training of Tyler Zeronda

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology